Skip to site navigation

Latest Biomedical Sciences News

Winners announced for £2m programme to commercialise life sciences discoveries

Publication date:

A cure for pancreatic cancer, virtual reality rehabilitation, data-driven robotic surgery, and futuristic wound-healing technology are just four of the 16 projects selected for MedCity’s ‘Collaborate to Innovate’ programme.

Embrace exhibition to help raise funds for new UCL Institute of Immunity and Transplantation

Publication date:

Installation, suspended from the ceiling

Embrace, a new exhibition opened this week at the Saatchi Gallery. The show, by Aisha Cahn, a contemporary British artist, is inspired by the science of cells, and the narrative of her mother's experience with cancer. Despite cancer eventually taking her life, the way in which she and Aisha approached the terminal prognosis together, was one of positivity, achieved through advanced medical treatment, faith and spirituality.

MRI scans can help spot HIV in the brain

Publication date:

MRI scanner

Scientists at UCL have developed a way to use MRI scans to help identify when HIV is persisting in the brain despite effective drug treatment.

'Brute force' can overcome antibiotic resistance

Publication date:

Mechanism of action for oritavancin

Antibiotics can still kill drug-resistant bacteria if they 'push' hard enough into bacterial cells, finds new UCL-led research funded by the Engineering and Physical Sciences Research Council.

New non-invasive test to detect bladder cancer could spare patients cystoscopy

Publication date:

Urine analysis

A new test for bladder cancer could enable GPs to test a urine sample and spare patients the discomfort of a cystoscopy in hospital, according to UCL research published today in Clinical Epigenetics.

Gene key for chemically reprogramming human stem cells

Publication date:

Test tubes

Scientists have discovered the gene essential for chemically reprogramming human amniotic stem cells into a more versatile state similar to embryonic stem cells, in research led by UCL and Heinrich Heine University.

Study shows how HIV breaches macrophage defences, could be step towards cure

Publication date:

HIV-infected macrophage

A team led by UCL researchers has identified how HIV is able to infect macrophages, a type of white blood cell integral to the immune system, despite the presence of a protective protein. They discovered a treatment that can maintain macrophage defences which could be a key part of the puzzle of reaching a complete cure for HIV/AIDS.

Delirium could accelerate dementia-related mental decline

Publication date:

The Neuronal Forest

When hospitalised, people can become acutely confused and disorientated. This condition, known as delirium, affects a quarter of older patients and new research by UCL and University of Cambridge shows it may have long-lasting consequences, including accelerating the dementia process.

Gene discovery helps children with movement disorder walk again

Publication date:

Brain

UCL researchers have discovered a new genetic cause for dystonia, a movement disorder, enabling treatment with Deep Brain Stimulation which has been so successful that children have been able to walk again.

Light therapy effectively treats early prostate cancer

Publication date:

Professor Mark Emberton

A new non-surgical treatment for low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new UCL-led phase III clinical trial in 413 patients. The trial was funded by STEBA Biotech which holds the commercial license for the treatment.

New £250m UK Dementia Research Institute to be led from UCL

Publication date:

MRI scan showing brain changes in dementia

UCL has been selected as the 'hub' of the new £250m UK Dementia Research Institute (UK DRI), to be led by Professor Bart De Strooper, current leader of the Laboratory for the Research of Neurodegenerative Diseases at the University of Leuven and scientific director at VIB (Vlaams Instituut voor Biotechnologie) in Belgium.

Glaucoma drug may have potential to treat Alzheimer’s disease

Publication date:

test tubes

A drug which is used to treat the common eye disease glaucoma may have potential as a treatment for Alzheimer’s disease, according to scientists at UCL.

Wellcome invests £24.1M in Research Centres at UCL

Publication date:

Wellcome Trust Centre for Neuroimaging

Wellcome has today announced funding for two Wellcome Trust Centres at UCL. Wellcome Centres aim to advance our understanding of health and disease, and span fundamental and social sciences, clinical research and engineering.

Women with dementia receive less medical attention

Publication date:

Woman in care home

Women with dementia have fewer visits to the GP, receive less health monitoring and take more potentially harmful medication than men with dementia, new UCL research reveals.

HIV patients showing signs of multidrug resistance in Africa

Publication date:

Drugs including tenofovir

Significant numbers of patients whose HIV strains developed resistance to older generation drugs are also resistant to modern drugs, finds a new study led by UCL and funded by Wellcome.

UCL spin-outs at heart of new £1 billion life sciences investment group

Publication date:

test-tubes_523x349.jpg

UCL spin-out companies will be at the heart of a new £1 billion life sciences company which has been created by three major investors in cancer research and other biotech fields. 

Pain sensors specialised for specific sensations

Publication date:

UCL research mouse

Many pain-sensing nerves in the body are thought to respond to all types of ‘painful events’, but new UCL research in mice reveals that in fact most are specialised to respond to specific types such as heat, cold or mechanical pain.

Top ten universities conduct a third of all UK animal research

Publication date:

UCL animal research facility

The ten UK universities who do the most world-leading biomedical research have announced their animal research statistics, revealing that they collectively conducted a third of all UK animal research in 2015.

“Some is good, more is better”: Regular exercise can cut your diabetes risk

Publication date:

Cycling

Walking briskly or cycling for the recommended 150 minutes a week can reduce a person’s risk of developing type 2 diabetes by up to 26%, according to new research by UCL.

New research sheds light on role of HPV in head and neck cancers

Publication date:

HPV

Human Papillomavirus (HPV) drives a greater number of head and neck cancers than previously thought, finds new research from UCL and the University of Southampton.

UCL spin-out Achilles Therapeutics to develop immunotherapies for cancer

Publication date:

Test tubes

A new spin-out company Achilles Therapeutics has been launched to develop immunotherapies for cancer, based on the work of scientists from UCL and its associated hospitals.

UCL’s innovative retail coalition celebrates first anniversary

Publication date:

UCL.DRI_Bags_Small.jpg

UCL is today marking one year since the launch of the innovative retail coalition inspired by Malcolm Walker of Iceland Foods to address the dementia challenge. Since the coalition was created nine UK retailers have committed to support UCL in its fight against dementia, initially pledging in the region of £20 million. In the first year alone, the partnership has already raised around £10 million – equivalent to the sale of around 200 million carrier bags.

UCL launches £600m philanthropy campaign  

Publication date:

Provost UCL Campaign

UCL is aiming to raise £600m for cutting-edge research, transformative capital projects and expanded student support in a new fundraising and engagement campaign, It’s All Academic – The Campaign for UCL, launched today in London.

UCL receives largest share of NHS research funding

Publication date:

UCL's Cruciform building

UCL’s three biomedical research centres (BRCs) have won more than £167 million in funding from the National Institute for Health Research (NIHR) to further world-leading biomedical research conducted with partner hospitals. UCL has received more funding than any other UK university, followed by King's College London and Oxford University, which received £133m and £127m respectively.

Vice-Provost (Research) to chair new Forum for Responsible Metrics

Publication date:

David Price

A new Forum for Responsible Metrics, to be chaired by Professor David Price, UCL Vice-Provost (Research), will bring together research funders, sector bodies and infrastructure experts to promote the responsible use of research metrics.

Search UCL News